source
- Acceleron leaders and Westlake jumpstart new IPF biotechAfter success with the drug Winrevair, a band of entrepreneurs has found their next challenge in a difficult-to-treat lung disease. On Tuesday, Oorja Bio launched with a $30 million Series A round,…Endpoints · 2mo ago↗ source
- STAT+: Canadian medical societies lack sufficient conflict-of-interest policies, study findsMost Canadian medical societies lack comprehensive policies governing conflicts of interest, and many policies are generally fragmented and narrow in scope, according to a new analysis.STAT · 2mo ago↗ source
- STAT+: At a time of tumult at FDA, a former commissioner is hopeful it’s on a better pathWith the FDA facing upheaval and personnel exits, former commissioner David Kessler sees an opportunity whereby the agency can make a turn for the better.